Commutability evaluation of glycated albumin candidate EQA materials
- 22 May 2025
- journal article
- research article
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 63 (10) , 2059-2066
Abstract
Objectives: In clinical practice, glycated albumin (GA), as a key biomarker reflecting the level of blood glucose control in the short and medium term, has been widely used in the diagnosis and efficacy monitoring of diabetes. However, the consistency of GA results between different detection systems remains one of the current challenges in laboratory medicine. we evaluated the commutability of 10 evaluated samples to identify candidate EQA materials for GA measurement. Methods: According to the Clinical and Laboratory Standards Institute (CLSI) document EP14-A3 and the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) commutability evaluation program, we used the established isotope dilution liquid chromatography-tandem mass spectrometry (ID LC-MS/MS) method for serum glycated albumin determination as the comparative method, and six different commercial kits used enzyme assay as the evaluating method. A total of 40 clinical sample serums, 9 pregnancy sample serums, and 10 evaluated samples were analyzed. Results: For the CLSI approach, pooled serum samples (cRM1-3) at medium concentrations (cRM2) are commutable in 5/6 kits. For the IFCC approach, none of samples commutable. Conclusions: The commutability evaluation results of the two approaches were different, and the cRM2 has commutability in most enzymatic kits. It can be a commutable material for the EQA project.Keywords
Funding Information
- National Key Research and Development Program of China (2022YFF0710305)
This publication has 14 references indexed in Scilit:
- IDF diabetes Atlas: Global estimates of undiagnosed diabetes in adults for 2021Diabetes Research and Clinical Practice, 2022
- Review of methods for detecting glycemic disordersDiabetes Research and Clinical Practice, 2020
- Glycated albuminClinica Chimica Acta, 2020
- Establishment of glycated albumin unit conversion equation from the standardized value (mmol/mol) to the routinely used value (%)Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2018
- Commutability and traceability in EQA programsClinical Biochemistry, 2018
- IFCC Working Group Recommendations for Assessing Commutability Part 2: Using the Difference in Bias between a Reference Material and Clinical SamplesClinical Chemistry, 2018
- IFCC Working Group Recommendations for Assessing Commutability Part 1: General Experimental DesignClinical Chemistry, 2018
- IFCC Working Group Recommendations for Assessing Commutability Part 3: Using the Calibration Effectiveness of a Reference MaterialClinical Chemistry, 2018
- An overview of in vitro and in vivo glycation of albumin: a potential disease marker in diabetes mellitusGlycoconjugate Journal, 2017
- Committee on Diabetes Mellitus Indices of the Japan Society of Clinical Chemistry-recommended reference measurement procedure and reference materials for glycated albumin determinationAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2015